Evolus (EOLS) Change in Receivables (2019 - 2026)
Evolus (EOLS) reported Change in Receivables of -$2.2 million for Q1 2026, down 361.73% on a YoY basis from $823000.0 in Q1 2025, and down 144.95% quarter-over-quarter from $4.8 million in Q4 2025.
Evolus (EOLS) Change in Receivables (2019 - 2026) Analysis & Trends
Evolus has reported Change in Receivables for 8 years, with the latest figure at -$2.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 361.73% year-over-year to -$2.2 million; the trailing twelve-month figure through Mar 2026 stood at $8.5 million (down 48.37% YoY), and the FY2025 full-year result was $11.5 million, down 41.29% from the prior year.
- Change in Receivables for Q1 2026 stood at -$2.2 million, down from $4.8 million in the prior quarter.
- The five-year high for Change in Receivables was $9.5 million in Q2 2024, with the low at -$2.2 million in Q1 2026.
- Historically, Change in Receivables has averaged $2.8 million across 5 years, with a median of $2.5 million in 2023.
- Annual changes were most pronounced in 2024 — Change in Receivables jumped 2435.76% — and 2026, when it sank 361.73%.
- Evolus' Change in Receivables stood at $1.8 million in 2022, then plunged by 91.44% to $151000.0 in 2023, then jumped by 2435.76% to $3.8 million in 2024, then increased by 25.15% to $4.8 million in 2025, then tumbled by 144.95% to -$2.2 million in 2026.
- The last three Change in Receivables figures came in at -$2.2 million (Q1 2026), $4.8 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Evolus | 437.40 Mn | 387.61 Mn | 48.90 Mn | -2.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.15 Mn |
| Mar 31, 2026 | -2.15 Mn |
| Dec 31, 2025 | 4.79 Mn |
| Dec 31, 2025 | 4.79 Mn |
| Sep 30, 2025 | 4.94 Mn |
| Sep 30, 2025 | 4.94 Mn |
| Jun 30, 2025 | 958,000.00 |
| Jun 30, 2025 | 958,000.00 |
| Mar 31, 2025 | 823,000.00 |
| Mar 31, 2025 | 823,000.00 |
| Dec 31, 2024 | 3.83 Mn |
| Dec 31, 2024 | 3.83 Mn |
| Sep 30, 2024 | 2.38 Mn |
| Sep 30, 2024 | 2.38 Mn |
| Jun 30, 2024 | 9.49 Mn |
| Jun 30, 2024 | 9.49 Mn |
| Mar 31, 2024 | 3.90 Mn |
| Mar 31, 2024 | 3.90 Mn |
| Dec 31, 2023 | 151,000.00 |
| Dec 31, 2023 | 151,000.00 |